Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-03 Sale | 2024-10-07 7:38 pm | CONDUIT PHARMACEUTICALS INC. | CDT | Nirland Ltd Stockton Ltd Rowland Master Trust Dovet Ltd 10% Owner | 3,808,000 | $0.10332 | $393,439 | 6,092,000 (Direct) | View |
| 2024-09-30 Sale | 2024-10-02 5:02 pm | CONDUIT PHARMACEUTICALS INC. | CDT | Nirland Ltd Stockton Ltd Rowland Master Trust Dovet Ltd 10% Owner | 2,600,000 | $0.11448 | $297,644 | 9,900,000 (Direct) | View |
| 2024-07-03 Sale | 2024-09-19 5:01 pm | CONDUIT PHARMACEUTICALS INC. | CDT | Regan Andrew Corvus Capital Ltd. Algo Holdings Inc. Director 10% Owner | 15,301,068 | $0.30014 | $4,592,487 | 2,444,277 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-18 Option Award | 2024-11-20 4:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Director | 437,976 | $0.0919 | 2,958,287 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 4:30 pm | N/A 2034-11-18 | CONDUIT PHARMACEUTICALS INC. | CDT | Tapolczay David Chief Executive Officer | 840,000 | $0.0919 | 840,000 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 4:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director | 299,238 | $0.0919 | 351,510 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 4:30 pm | N/A 2034-11-18 | CONDUIT PHARMACEUTICALS INC. | CDT | Bligh James Interim CFO | 1,890,000 | $0.0919 | 1,890,000 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 4:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director | 75,000 | $0 | 341,594 (Direct) | View |
| 2024-11-18 Option Award | 2024-11-20 4:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director | 266,594 | $0.0919 | 341,594 (Direct) | View |
| 2024-06-14 Other | 2024-09-19 5:01 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Regan Andrew Corvus Capital Ltd. Algo Holdings Inc. Director 10% Owner | 1,100,000 | $0 | 2,444,277 (Indirect) | View |
Ownership | 2024-08-13 4:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Nirland Ltd Stockton Ltd Rowland Master Trust Dovet Ltd 10% Owner | 0 | $0 | 14,500,000 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-11 5:56 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director | 37,272 | $0 | 52,272 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-11 5:53 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Bligh James Interim CFO | 37,272 | $0 | 37,272 (Direct) | View |
| 2024-05-15 Disposition | 2024-05-15 4:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Sragovicz Adam Chief Financial Officer | 74,545 | $0 | 0 (Direct) | View |
| 2024-05-13 Disposition | 2024-05-15 4:30 pm | N/A 2033-11-30 | CONDUIT PHARMACEUTICALS INC. | CDT | McNealey Jennifer Isacoff Director | 65,000 | $5.51 | 0 (Direct) | View |
| 2024-04-22 Option Award | 2024-04-24 5:00 pm | 2025-04-22 2027-04-22 | CONDUIT PHARMACEUTICALS INC. | CDT | Tapolczay David Chief Executive Officer | 400,664 | $0 | 600,996 (Direct) | View |
| 2024-04-22 Option Award | 2024-04-24 5:00 pm | 2025-04-22 2027-04-22 | CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Intelmed LLC Director | 504,061 | $0 | 504,061 (Indirect) | View |
| 2024-04-22 Option Award | 2024-04-24 5:00 pm | 2025-04-22 2027-04-22 | CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director | 3,000 | $0 | 206,332 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-14 5:16 pm | N/A 2033-11-30 | CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Director | 65,000 | $5.51 | 65,000 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-05 5:20 pm | N/A 2033-11-30 | CONDUIT PHARMACEUTICALS INC. | CDT | Bligh James Director | 223,634 | $5.51 | 223,634 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-05 5:20 pm | N/A 2033-11-30 | CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director | 65,000 | $5.51 | 65,000 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-05 5:20 pm | N/A 2033-11-30 | CONDUIT PHARMACEUTICALS INC. | CDT | McNealey Jennifer Isacoff Director | 65,000 | $5.51 | 65,000 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-05 5:20 pm | N/A 2033-11-30 | CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director | 65,000 | $5.51 | 65,000 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-05 5:20 pm | N/A 2033-11-30 | CONDUIT PHARMACEUTICALS INC. | CDT | Tapolczay David Director | 298,179 | $5.51 | 298,179 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-05 5:20 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Sragovicz Adam Chief Financial Officer | 74,545 | $0 | 74,545 (Direct) | View |
| 2023-09-22 Option Award | 2023-09-26 5:49 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director | 15,000 | $0 | 30,000 (Direct) | View |
| 2023-09-22 Option Award | 2023-09-26 5:49 pm | N/A 2028-10-22 | CONDUIT PHARMACEUTICALS INC. | CDT | Farley Chele Chiavacci Director | 15,000 | $11.5 | 30,000 (Direct) | View |
Ownership | 2023-09-26 5:41 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Lewis-Hall Freda C Intelmed LLC Director | 0 | $0 | 2,520,311 (Indirect) | View |
Ownership | 2023-09-26 5:37 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Regan Andrew Corvus Capital Ltd. Algo Holdings Inc. Director 10% Owner | 0 | $0 | 45,593,799 (Direct) | View |
Ownership | 2023-09-26 5:34 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Tapolczay David Chief Executive Officer | 0 | $0 | 2,003,324 (Direct) | View |
| 2023-09-22 Other | 2023-09-26 5:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Heilbron Jack Kendrick Murphy Canyon Acquisition Sponsor LLC Former CEO,director&10% owner | 45,000 | $0 | 5,523,250 (Indirect) | View |
| 2023-09-22 Exercise | 2023-09-26 5:30 pm | N/A N/A | CONDUIT PHARMACEUTICALS INC. | CDT | Heilbron Jack Kendrick Murphy Canyon Acquisition Sponsor LLC Former CEO,director&10% owner | 4,060,250 | $0 | 5,523,250 (Indirect) | View |
| 2023-09-22 Exercise | 2023-09-26 5:30 pm | 2023-10-22 2028-09-22 | CONDUIT PHARMACEUTICALS INC. | CDT | Heilbron Jack Kendrick Murphy Canyon Acquisition Sponsor LLC Former CEO,director&10% owner | 754,000 | $11.5 | 5,523,250 (Indirect) | View |
| 2023-09-22 Other | 2023-09-26 5:30 pm | 2023-10-22 2028-09-22 | CONDUIT PHARMACEUTICALS INC. | CDT | Heilbron Jack Kendrick Murphy Canyon Acquisition Sponsor LLC Former CEO,director&10% owner | 45,000 | $11.5 | 5,523,250 (Indirect) | View |
Ownership | 2023-02-08 11:30 am | N/A N/A | Murphy Canyon Acquisition Corp. | MURF | Shaolin Capital Management LLC 10% Owner | 0 | $0 | 616,950 (Direct) | View |
Ownership | 2022-02-11 4:31 pm | N/A N/A | Murphy Canyon Acquisition Corp. | MURF | Murphy Canyon Acquisition Sponsor LLC 10% Owner | 0 | $0 | 4,625,750 (Direct) | View |
Ownership | 2022-02-11 4:30 pm | N/A N/A | Murphy Canyon Acquisition Corp. | MURF | Heilbron Jack Kendrick CEO, President, and Chairman | 0 | $0 | 4,625,750 (Indirect) | View |